陈旧的、新颖的、或多或少的以及心血管疾病生物标志物的难题？
Old, the new, more or less and the conundrum for biomarkers in cardiovascular diseases?
作者信息
Iyngkaran Pupalan
机构信息
Department of Cardiology, Notre Dame University, Werribee 3029, Australia.
Department of Public Health, Torrens Univeristy Australia, Melbourne 3004, Victoria, Australia.
出版信息
World J Clin Cases. 2024 Oct 6;12(28):6244-6246. doi: 10.12998/wjcc.v12.i28.6244.
Abstract
Biomarkers are critical for diagnostic, monitoring and management of cardiovascular diseases. Opportunities to improve how biomarkers are used are important. This editorial on biomarkers in coronary artery disease provides commentary on the study as well as broad benchmarks on what make ideal biomarkers. Biomarker discovery is difficult and opportunities to expand and improve their use should be encouraged.
摘要
生物标志物对于心血管疾病的诊断、监测和管理至关重要。改善生物标志物使用方式的机会很重要。这篇关于冠状动脉疾病中生物标志物的社论对该研究进行了评论，并给出了关于理想生物标志物的广泛基准。生物标志物的发现很困难，应鼓励扩大和改善其使用的机会。
相似文献
1
Old, the new, more or less and the conundrum for biomarkers in cardiovascular diseases?陈旧的、新颖的、或多或少的以及心血管疾病生物标志物的难题？
World J Clin Cases. 2024 Oct 6;12(28):6244-6246. doi: 10.12998/wjcc.v12.i28.6244.
2
Beyond cardiac troponin: recent advances in the development of alternative biomarkers for cardiovascular disease.超越心肌肌钙蛋白：心血管疾病替代生物标志物开发的最新进展
Expert Rev Mol Diagn. 2015 Apr;15(4):547-56. doi: 10.1586/14737159.2015.1010519. Epub 2015 Feb 12.
3
Prognostic significance of biomarkers in predicting outcome in patients with coronary artery disease and left ventricular dysfunction: results of the biomarker substudy of the Surgical Treatment for Ischemic Heart Failure trials.生物标志物在预测冠心病合并左心室功能障碍患者结局中的预后意义：缺血性心力衰竭手术治疗试验生物标志物亚研究的结果。
Circ Heart Fail. 2013 May;6(3):461-72. doi: 10.1161/CIRCHEARTFAILURE.112.000185. Epub 2013 Apr 12.
4
Role of Selected miRNAs as Diagnostic and Prognostic Biomarkers in Cardiovascular Diseases, Including Coronary Artery Disease, Myocardial Infarction and Atherosclerosis.特定微小RNA作为心血管疾病（包括冠状动脉疾病、心肌梗死和动脉粥样硬化）诊断和预后生物标志物的作用
J Cardiovasc Dev Dis. 2021 Feb 19;8(2):22. doi: 10.3390/jcdd8020022.
5
Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease.评估心血管应激的多种生物标志物，用于稳定型冠心病患者的风险预测和指导医学治疗。
Circulation. 2012 Jan 17;125(2):233-40. doi: 10.1161/CIRCULATIONAHA.111.063842. Epub 2011 Dec 16.
6
Ideal cardiovascular health, biomarkers, and coronary artery disease in persons with HIV.理想心血管健康、生物标志物与 HIV 感染者的冠状动脉疾病。
AIDS. 2023 Mar 1;37(3):423-434. doi: 10.1097/QAD.0000000000003418. Epub 2022 Nov 18.
7
Non-alcoholic fatty liver disease biomarkers estimate cardiovascular risk based on coronary artery calcium score in type 2 diabetes: a cross-sectional study with two independent cohorts.非酒精性脂肪性肝病生物标志物基于冠状动脉钙评分估计 2 型糖尿病患者的心血管风险：两项独立队列的横断面研究。
Cardiovasc Diabetol. 2024 Feb 13;23(1):69. doi: 10.1186/s12933-024-02161-x.
8
Sepsis Care Pathway 2019.2019年脓毒症护理路径
Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019.
9
Biomarkers and cardiovascular events in patients with stable coronary disease in the ISCHEMIA Trials.缺血性试验中稳定型冠心病患者的生物标志物与心血管事件。
Am Heart J. 2023 Dec;266:61-73. doi: 10.1016/j.ahj.2023.08.007. Epub 2023 Aug 19.
10
Diagnostic value of multimodal cardiovascular imaging technology coupled with biomarker detection in elderly patients with coronary heart disease.多模态心血管成像技术联合生物标志物检测在老年冠心病患者中的诊断价值
Br J Hosp Med (Lond). 2024 Jun 30;85(6):1-10. doi: 10.12968/hmed.2024.0123. Epub 2024 Jun 26.
本文引用的文献
1
Serum cystatin C, monocyte/high-density lipoprotein-C ratio, and uric acid for the diagnosis of coronary heart disease and heart failure.血清胱抑素C、单核细胞/高密度脂蛋白-C比值及尿酸用于冠心病和心力衰竭的诊断。
World J Clin Cases. 2024 Jun 26;12(18):3461-3467. doi: 10.12998/wjcc.v12.i18.3461.
2
Discovering biomarkers associated and predicting cardiovascular disease with high accuracy using a novel nexus of machine learning techniques for precision medicine.利用机器学习技术的新型融合，准确发现与心血管疾病相关的生物标志物并进行预测，为精准医疗提供支持。
Sci Rep. 2024 Jan 2;14(1):1. doi: 10.1038/s41598-023-50600-8.
3
Circulating cardiac biomarkers improve risk stratification for incident cardiovascular disease in community dwelling populations.循环心脏标志物可改善社区居民新发心血管疾病的风险分层。
EBioMedicine. 2022 Aug;82:104170. doi: 10.1016/j.ebiom.2022.104170. Epub 2022 Jul 15.
4
Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future.心血管生物标志物：过去的经验教训与未来展望。
Int J Mol Sci. 2022 May 19;23(10):5680. doi: 10.3390/ijms23105680.
5
Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients With Cardiovascular Disease.用于心血管疾病患者心血管疾病风险预测的循环生物标志物
Front Cardiovasc Med. 2021 Oct 1;8:713191. doi: 10.3389/fcvm.2021.713191. eCollection 2021.
6
Circulating biomarkers for predicting cardiovascular disease risk; a systematic review and comprehensive overview of meta-analyses.循环生物标志物预测心血管疾病风险：系统评价和荟萃分析综合概述。
PLoS One. 2013 Apr 22;8(4):e62080. doi: 10.1371/journal.pone.0062080. Print 2013.
7
Biomarkers in cardiovascular medicine.心血管医学中的生物标志物。
Rev Esp Cardiol. 2009 Jun;62(6):677-88. doi: 10.1016/s1885-5857(09)72232-7.
8
Cardiovascular biomarkers: added value with an integrated approach?心血管生物标志物：综合方法的附加价值？
Circulation. 2007 Jul 3;116(1):3-5. doi: 10.1161/CIRCULATIONAHA.107.707984.
9
Biomarkers of cardiovascular disease: molecular basis and practical considerations.心血管疾病的生物标志物：分子基础与实际考量
Circulation. 2006 May 16;113(19):2335-62. doi: 10.1161/CIRCULATIONAHA.104.482570.
10
Prevalence of conventional risk factors in patients with coronary heart disease.冠心病患者中传统危险因素的患病率。
JAMA. 2003 Aug 20;290(7):898-904. doi: 10.1001/jama.290.7.898.
Zotero 插件